ELI LILLY & Co (LLY) stock
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1415.55−16.12 (-1.13%)
Close on Nov 17, 2026Market cap $1.33TP/E 45.9Yield 0.44%
Eli Lilly price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Eli Lilly's price to book ratio was 38.0× on Nov 11, 2026, against 40.7× a year earlier. Over the last 5 years it ranged from 25.4× to 65.5×, with a median of 38.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 38.0× | −2.6 |
| 2025 | Dec 31, 2025 | 40.7× | −8.3 |
| 2024 | Dec 31, 2024 | 49.0× | +2.1 |
| 2023 | Dec 29, 2023 | 46.9× | +14.0 |
| 2022 | Dec 30, 2022 | 32.9× | +0.4 |
| 2021 | Dec 31, 2021 | 32.5× | +0.6 |
| 2020 | Dec 31, 2020 | 31.9× | −5.5 |
| 2019 | Dec 31, 2019 | 37.4× | +28.2 |
| 2018 | Dec 31, 2018 | 9.2× | +3.2 |
| 2017 | Dec 29, 2017 | 6.0× | +1.0 |
| 2016 | Dec 30, 2016 | 5.0× | −0.9 |
| 2015 | Dec 31, 2015 | 5.9× | +1.7 |
| 2014 | Dec 31, 2014 | 4.2× | +0.8 |
| 2012 | Apr 30, 2012 | 3.4× | – |
See a number that looks wrong?